Pulmonx Corporation Common Stock LUNG
i
Market dataready · fetched 2026-11-12T03:18:18.885Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:17:06.360420799Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T03:18:12.058692+00:00
Pulmonx Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 2.70 | 107.0% | 19.4% | |||
| 35Δ | 2.92 | 109.6% | 17.8% | |||
| 40Δ | 3.13 | 112.3% | 16.2% | |||
| 45Δ | 3.34 | 115.0% | 14.6% | |||
| 50Δ | 3.55 | 117.7% | 13.1% | |||
| 55Δ | 3.76 | 120.4% | 11.5% | |||
| 60Δ | 3.97 | 123.1% | 9.9% | |||
| 65Δ | 2.91 | 118.7% | 18.3% | 4.19 | 125.7% | 8.3% |
| 70Δ | 2.68 | 115.1% | 12.1% | 4.40 | 128.4% | 6.7% |
| 75Δ | 2.47 | 111.0% | 6.8% | 4.61 | 131.1% | 5.1% |
| 80Δ | 2.35 | 105.2% | 5.3% | 4.82 | 133.8% | 3.5% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.70
- IV
- 107.0%
- B/E move
- 19.4%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.92
- IV
- 109.6%
- B/E move
- 17.8%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.13
- IV
- 112.3%
- B/E move
- 16.2%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.34
- IV
- 115.0%
- B/E move
- 14.6%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.55
- IV
- 117.7%
- B/E move
- 13.1%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.76
- IV
- 120.4%
- B/E move
- 11.5%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.97
- IV
- 123.1%
- B/E move
- 9.9%
65Δ
- Pseudo strike
- 2.91
- IV
- 118.7%
- B/E move
- 18.3%
- Pseudo strike
- 4.19
- IV
- 125.7%
- B/E move
- 8.3%
70Δ
- Pseudo strike
- 2.68
- IV
- 115.1%
- B/E move
- 12.1%
- Pseudo strike
- 4.40
- IV
- 128.4%
- B/E move
- 6.7%
75Δ
- Pseudo strike
- 2.47
- IV
- 111.0%
- B/E move
- 6.8%
- Pseudo strike
- 4.61
- IV
- 131.1%
- B/E move
- 5.1%
80Δ
- Pseudo strike
- 2.35
- IV
- 105.2%
- B/E move
- 5.3%
- Pseudo strike
- 4.82
- IV
- 133.8%
- B/E move
- 3.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 153.41% | |
| 131.79% |
Medical Devices
MASS
Description unavailable
More →MBOT
Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting the minimally invasive surgery…
More →MDT
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in…
More →MXCT
MaxCyte Inc. (MXCT) is a leader in cell-engineering, renowned for its innovative Flow Electroporation® technology that enables efficient and scalable delivery of nucleic acids and…
More →NEOG
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
More →NNOX
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is…
More →